Description
| Specialty | COARAVEN |
|---|---|
| Dosage | 25 mg, 300 mg |
| Form | Film-coated tablet |
| Presentation | Box of 30 |
| Primary packaging | Blister |
| Specification | Opaque white PVC/PVDC/Alu |
| INN | Hydrochlorothiazide |
| VEIC Classification | Essential |
| Therapeutic class | Cardiovascular system |
| Subclass | Agents acting on the renin-angiotensin system |
| Laboratory | PHILADELPHIA PHARMA |
| Schedule | A |
| Shelf life | 24 months |
| Generic/Originator | Generic |
| Marketing Authorization (MA) | 9353044 |
| MA date | 2014-03-14 |
| Range | Cardio-Metabolic Range |







Reviews
There are no reviews yet.